Mottled skin in lupus usually takes the form of livedo reticularis, a net-like pattern of reddish-blue to purple discoloration most visible on the legs and arms. It shows up in roughly 12 to 25 percent of people with systemic lupus erythematosus (SLE), and while it can look alarming, the pattern itself ranges from a harmless cosmetic nuisance triggered by cold weather to a clinical signal that something more serious is happening in the blood vessels. The difference often hinges on what is driving the mottling, particularly whether antiphospholipid antibodies are involved.
What the Mottling Actually Looks Like
Livedo reticularis appears as a lace-like or fishnet pattern on the skin, typically with a reddish-blue or violet hue. The pattern forms because of how blood flows through small vessels in the skin. Arterioles feed cone-shaped regions of tissue, and where the edges of those cones meet, blood flow is slowest. When flow drops or oxygen delivery falters, those boundary zones turn blue, creating the characteristic mesh. The centers of the mesh, where blood flow is strongest, stay relatively normal in color.
In many people without lupus, this pattern appears temporarily when they get cold and fades when they warm up. That benign version is extremely common, especially in fair-skinned women, and is not considered a disease. In lupus, however, the mottling tends to be more persistent, more widespread, and less responsive to warming. It may cover large areas of the thighs, lower legs, trunk, or arms, and sometimes it does not fully disappear even in a warm environment.
Livedo Reticularis Versus Livedo Racemosa
Dermatologists draw an important distinction between two forms of mottled skin that look similar at first glance but behave differently. Classic livedo reticularis forms a regular, closed, symmetric net. Livedo racemosa, by contrast, forms broken, irregular, open-ended streaks that do not complete the circle. The distinction matters because racemosa is much more strongly linked to underlying disease.
Livedo racemosa is more commonly associated with antiphospholipid antibody syndrome (APS), a condition in which the immune system produces antibodies that increase clotting risk. In studies comparing the two patterns, patients with livedo racemosa had significantly higher levels of certain antiphospholipid antibodies, higher inflammatory markers, and a greater likelihood of skin ulceration and joint pain than patients with the regular reticularis pattern.1Rheumatology. Differences in anti-phosphatidylserine–prothrombin complex antibodies and cutaneous vasculitis between regular livedo reticularis and livedo racemosa The regular reticularis form, on the other hand, is often benign, particularly in middle-aged women without autoimmune disease.2PubMed Central. Livedo reticularis: A review of the literature
In practice, telling the two apart on sight can be tricky, even for experienced clinicians. The pattern does not always cooperate with the textbook description. When a lupus patient presents with persistent mottling, doctors tend to look beyond the skin pattern itself and focus on lab work, particularly antiphospholipid antibody testing, to figure out which category applies.
Why Antiphospholipid Antibodies Are the Key Link
The strongest predictor of livedo reticularis in lupus is not the lupus itself but the presence of antiphospholipid antibodies, especially anticardiolipin antibodies and lupus anticoagulant. In a case-control study of lupus patients, about four out of five patients with livedo reticularis had elevated anticardiolipin antibody levels. The odds of having livedo reticularis were roughly 23 times higher in those with elevated anticardiolipin levels compared to those without.3The American Journal of Medicine. Clinical and immunologic features of livedo reticularis in lupus: a case-control study That is a strikingly strong association.
These antibodies promote clotting in small blood vessels, which reduces blood flow through the skin’s microcirculation. The result is that distinctive blue-purple network. The same clotting tendency also raises the risk of more dangerous events elsewhere in the body, including deep vein thrombosis, pulmonary embolism, and stroke. That is why mottled skin in lupus is not treated as purely cosmetic. It can be an outward sign that a patient is at elevated thrombotic risk.
Livedo reticularis is considered one of the less specific findings of APS, meaning it can appear in APS but also in other conditions. Still, when it shows up in a lupus patient alongside other APS features like a history of blood clots or low platelet counts, it strengthens the clinical picture considerably.4PubMed. Cutaneous manifestations of antiphospholipid antibody syndrome
How Common Is Mottled Skin in Lupus
Prevalence estimates vary depending on the cohort studied and how carefully clinicians look for it. One literature review places the range at about 12 to 26 percent of people with SLE across different study populations. The mottling appears more frequently in patients with acute cutaneous lupus (around 10 percent) compared to those with chronic cutaneous forms (around 3 percent), which suggests it tracks more closely with active systemic disease than with localized skin-only lupus.5Synapse (Journal List > J Rheum Dis > v.33(3)). Non-specific cutaneous lupus erythematosus and clinical significance: a literature review
Patients with livedo reticularis are also more likely to have systemic organ involvement beyond the skin. In one analysis, systemic disease involvement was present in about 57 percent of lupus patients with livedo reticularis, compared to roughly 25 percent of those without it. That gap is large enough that many rheumatologists treat new-onset livedo in a lupus patient as a prompt to check for worsening systemic activity, not just a skin complaint to manage on its own.
What Mottled Skin Signals About Thrombotic Risk
The clotting connection is the reason doctors take livedo reticularis in lupus seriously. The same study that found the 23-fold increase in odds with anticardiolipin antibodies also found that a history of blood clots and low platelet counts were significantly more common in lupus patients who had livedo compared to those who did not.6The American Journal of Medicine. Clinical and immunologic features of livedo reticularis in lupus: a case-control study In other words, the mottled skin is not an isolated cosmetic issue. It clusters with the very complications that make APS dangerous.
An extreme example of this relationship is Sneddon’s syndrome, a rare condition in which livedo racemosa occurs alongside cerebrovascular disease, primarily strokes and transient ischemic attacks caused by small-vessel ischemia. Sneddon’s syndrome can occur with or without antiphospholipid antibodies, but it illustrates how the same vascular changes that produce mottled skin can also affect the brain.7PubMed Central. Sneddon’s syndrome: a comprehensive review of the literature Clinicians evaluating a lupus patient with widespread livedo and any neurological symptoms, even subtle ones like recurrent headaches or transient confusion, will often investigate this possibility.
Getting a Diagnosis
Mottled skin in someone already diagnosed with lupus is usually recognized during a routine visit or when the patient points it out. The real diagnostic work happens underneath the surface. A doctor seeing persistent livedo in a lupus patient will typically order antiphospholipid antibody panels, including anticardiolipin antibodies, anti-beta-2-glycoprotein I antibodies, and lupus anticoagulant testing. These results determine whether the mottling is incidental or a marker for APS, which carries its own management implications.
Skin biopsy is sometimes performed but often unrevealing. The mottling results from functional changes in blood flow, not always from structural damage visible under a microscope. When there is visible tissue damage, biopsy may show small-vessel thrombosis, but a normal biopsy does not rule out a significant vascular problem.
Newer tools for assessing the microvasculature are being explored. Capillaroscopy, which uses a magnifying tool to look at tiny blood vessels near the nail bed, and laser imaging techniques can detect microvascular changes in lupus patients that are not visible to the naked eye.8PubMed Central. Microvascular involvement in systemic sclerosis and systemic lupus erythematosus These are primarily research tools at this point, but they may eventually help identify patients at high risk for vascular complications before problems like mottled skin even become visible.
Treatment and Management
How mottled skin in lupus gets treated depends entirely on what is causing it. If the livedo is mild, comes and goes, and is not associated with antiphospholipid antibodies or other vascular problems, the approach is conservative. Avoiding cold exposure and substances that constrict blood vessels (like nicotine and certain decongestants) can help reduce the visibility of the pattern. In some cases, a calcium channel blocker, a type of medication that relaxes blood vessels, may be prescribed for mild symptoms like episodic numbness or tingling.9PubMed. Livedo reticularis and related disorders
When the livedo is associated with antiphospholipid antibodies or a confirmed APS diagnosis, treatment shifts to addressing the underlying clotting risk. This usually means anticoagulation therapy, often with warfarin or similar blood thinners, particularly if the patient has already had a clotting event. Managing the lupus itself with immunosuppressive therapy may also reduce the skin changes, since controlling systemic inflammation can improve the microvascular environment. The key principle is that treating the livedo pattern directly is less effective than treating what is driving it.10PubMed. Livedo reticularis and related disorders
For patients whose main concern is the appearance, the mottling can be frustrating because it does not respond to topical creams or cosmetic treatments. Compression garments may modestly improve the look by promoting better venous return, but the effect is usually subtle. Honest expectation-setting matters here: the pattern may fluctuate but is unlikely to disappear completely as long as the underlying process is active.
Mottled Skin and Pregnancy in Lupus
Pregnancy in lupus is already considered high risk, and the presence of antiphospholipid antibodies makes it more so, increasing the chance of miscarriage, preeclampsia, and placental insufficiency. What makes livedo reticularis particularly interesting in this context is that widespread mottling may signal pregnancy risk even in lupus patients who test negative for antiphospholipid antibodies. One study found that pregnancy loss was independently associated with widespread livedo reticularis in patients who did not have detectable antiphospholipid antibodies.11PubMed Central. Livedo reticularis and pregnancy morbidity in patients negative for antiphospholipid antibodies
This finding suggests that the microvascular changes underlying livedo may contribute to pregnancy complications through pathways that standard antibody testing does not fully capture. For lupus patients planning a pregnancy, the presence of widespread livedo reticularis, even in the absence of positive APS labs, could be relevant information for an obstetrician and rheumatologist to factor into risk assessment and monitoring plans.
Other Causes of Mottled Skin That Can Mimic Lupus
Not every case of mottled skin means lupus, and not every lupus patient with mottled skin has it because of lupus. The list of conditions that produce livedo-like patterns is long and includes some that have nothing to do with autoimmunity. Physiologic livedo reticularis, the common benign kind, affects many otherwise healthy people, especially in cold conditions. Cholesterol crystal emboli from atherosclerotic plaques can produce livedo, particularly in older patients after vascular procedures. Certain blood cancers, infections, and medications can also cause similar patterns.
In someone not already diagnosed with lupus or another autoimmune condition, persistent mottled skin warrants investigation rather than assumption. The clinical approach typically starts with blood work looking for antiphospholipid antibodies, signs of systemic inflammation, and autoimmune markers. A thorough medication review is also standard, since some drugs can trigger livedo as a side effect. The key takeaway for anyone noticing persistent net-like discoloration on their skin is that the pattern itself is not a diagnosis. It is a prompt to look deeper.
When Mottled Skin Changes or Worsens
For lupus patients who already know they have livedo reticularis, changes in the pattern can carry meaning. A pattern that was previously transient becoming persistent, or one that was limited to the legs spreading to the trunk and arms, can signal worsening microvascular involvement. New symptoms appearing alongside the mottling, such as skin ulcers, painful nodules, or dusky discoloration of fingertips and toes, deserve prompt medical attention.
Skin ulceration in particular is more closely linked with livedo racemosa than with the benign reticularis form, and the combination of livedo with ulceration strongly suggests active vascular inflammation or thrombosis.12Rheumatology. Differences in anti-phosphatidylserine–prothrombin complex antibodies and cutaneous vasculitis between regular livedo reticularis and livedo racemosa Lupus patients who notice these changes should not wait for a scheduled appointment. The progression from cosmetic mottling to tissue-threatening vascular disease can happen gradually, and catching it early makes a real difference in how well it responds to treatment.
Seasonal variation is common and usually benign. Many people with livedo notice it worsening in winter and improving in summer, simply because cold exposure amplifies the blood-flow patterns that create the mottled look. This kind of fluctuation, in the absence of new symptoms, is generally not a cause for concern. The changes that warrant action are those accompanied by pain, tissue damage, or new systemic symptoms like joint swelling, unusual fatigue, or neurological complaints.